SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?


To: StocksDATsoar who wrote (145571)7/22/2005 9:50:52 AM
From: rrufff  Respond to of 150070
 
Thanks SDS - CNVT - has a problem. As their holdings are not subsidiaries but "investments," the holdings show up on the balance sheet at cost and not current value. PR's indicate that net asset value is .85 a share or in that region. Yet, the stock sell for less than 25% of that.



To: StocksDATsoar who wrote (145571)7/22/2005 3:25:23 PM
From: rrufff  Respond to of 150070
 
HSHL + 45% my runner of the week.

This is one right up the alley (or maybe kazooo <ggg>) of us "alta kakas" "withered nerds" "youngsters at heart". After you get through sitting behind the 'puter I bet you'd rather have a nice cool Hemorrelief than a bunch of goooooooo. Besides you can keep that Prep H for the eyes.

Wait til you see what they do for the other end <gggg> with their new subsidiary.

Prostate Health Solutions, Inc. is in development of a product that provides stimulation and massaging of the prostate and prostate area in a manner that in the Company's opinion would reduce swelling and enlargement. The technology used is based upon similar technology used in Home Solutions Health Inc.'s patented and FDA approved Hemorrelief device. Upon final development and approval, the prostate device could help reduce the painful effects of prostatitis and possibly help inhibit other prostate diseases. Men over 45 years old are at high risk for prostate medical problems